Loading company details...
Beta
Latest Form 4 (Aug 6, 2026): Sarah Gheuens (Chief Medical Officer): Sale of 30,000 shares, $914.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 6, 2026 | Sarah Gheuens, Chief Medical Officer | Sale | 30,000 | $914.4K |
| Jul 10, 2026 | Jay T. Backstrom | Grant/Award | 1,447 | n/a |
| Jul 2, 2026 | Sarah Gheuens, Chief Medical Officer | Exercise/Conversion | 8,375 | n/a |
| Jun 23, 2026 | Rahul D. Ballal | Exercise/Conversion | 2,816 | n/a |
| Jun 23, 2026 | Jeffrey D. Capello | Exercise/Conversion | 2,816 | n/a |
| Jun 23, 2026 | Kaye I. Foster-Cheek | Exercise/Conversion | 2,816 | n/a |
| Jun 23, 2026 | Jacqualyn A. Fouse | Exercise/Conversion | 2,816 | n/a |
| Jun 23, 2026 | Maykin Ho | Exercise/Conversion | 2,816 | n/a |
| Jun 23, 2026 | Adams Catherine Owen | Exercise/Conversion | 2,816 | n/a |
| Jun 23, 2026 | David Scadden | Exercise/Conversion | 2,816 | n/a |